Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.
暂无分享,去创建一个
Robert Langer | Jinjun Shi | R. Langer | Jinjun Shi | Jun Wu | A. Radovic-Moreno | Aleksandar F Radovic-Moreno | Jun Wu | Xi Zhu | Xi Zhu
[1] Ulrich Amsel,et al. Bacterial Pathogenesis A Molecular Approach , 2016 .
[2] Surinder P. Singh,et al. The role of nanotechnology in combating multi-drug resistant bacteria. , 2014, Journal of nanoscience and nanotechnology.
[3] O. Farokhzad,et al. Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[4] J. Whittum-Hudson,et al. Folate-functionalized dendrimers for targeting Chlamydia-infected tissues in a mouse model of reactive arthritis. , 2014, International journal of pharmaceutics.
[5] Till F Schäberle,et al. Overcoming the current deadlock in antibiotic research. , 2014, Trends in microbiology.
[6] R. Terns,et al. CRISPR-based technologies: prokaryotic defense weapons repurposed. , 2014, Trends in genetics : TIG.
[7] Ashley Chessher,et al. Species-Selective Killing of Bacteria by Antimicrobial Peptide-PNAs , 2014, PloS one.
[8] Yi Yan Yang,et al. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin. , 2014, Biomaterials.
[9] M. Schoenfisch,et al. Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. , 2014, Biomaterials.
[10] Liangfang Zhang,et al. Hydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery , 2014, ACS nano.
[11] Xiaoyang Xu,et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.
[12] K. J. Jeong,et al. Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood. , 2014, Nano letters.
[13] Arti Kapi. The evolving threat of antimicrobial resistance: Options for action , 2014 .
[14] B. Limbago,et al. Report of the 13th Vancomycin-Resistant Staphylococcus aureus Isolate from the United States , 2013, Journal of Clinical Microbiology.
[15] Ronnie H. Fang,et al. Nanoparticle-detained toxins for safe and effective vaccination , 2013, Nature nanotechnology.
[16] Adam J Friedman,et al. Nanotechnology as a therapeutic tool to combat microbial resistance. , 2013, Advanced drug delivery reviews.
[17] K. Chennazhi,et al. Chitosan-hyaluronic acid/nano silver composite sponges for drug resistant bacteria infected diabetic wounds. , 2013, International journal of biological macromolecules.
[18] Robert Langer,et al. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug , 2013, Proceedings of the National Academy of Sciences.
[19] Yu-Chie Chen,et al. Lysozyme-encapsulated gold nanocluster-based affinity mass spectrometry for pathogenic bacteria. , 2013, Rapid communications in mass spectrometry : RCM.
[20] T. Webster,et al. Inhibited growth of Pseudomonas aeruginosa by dextran- and polyacrylic acid-coated ceria nanoparticles , 2013, International journal of nanomedicine.
[21] Douglas M. Smith,et al. Applications of nanotechnology for immunology , 2013, Nature Reviews Immunology.
[22] Ronald N. Jones,et al. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] Jin-Woo Kim,et al. Selective pathogen targeting and macrophage evading carbon nanotubes through dextran sulfate coating and PEGylation for photothermal theranostics. , 2013, Journal of biomedical nanotechnology.
[24] S. Singh,et al. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine , 2013, International journal of nanomedicine.
[25] S. Singh,et al. Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles , 2013, International journal of nanomedicine.
[26] J. Antonucci,et al. Effects of dual antibacterial agents MDPB and nano-silver in primer on microcosm biofilm, cytotoxicity and dentine bond properties. , 2013, Journal of dentistry.
[27] Hakho Lee,et al. A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria. , 2013, Nature nanotechnology.
[28] Vasiliki Demas,et al. T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood , 2013, Science Translational Medicine.
[29] Bernd Giese,et al. Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. , 2013, Chemical reviews.
[30] H. Kiyono,et al. Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae , 2013, Infection and Immunity.
[31] Christina Tobin Kåhrström. Environmental microbiology: Plant bacteria thrive in storm clouds , 2013, Nature Reviews Microbiology.
[32] J. Vadivelu,et al. Burkholderia vaccines: are we moving forward? , 2013, Front. Cell. Inf. Microbio..
[33] E. Azzopardi,et al. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. , 2013, The Journal of antimicrobial chemotherapy.
[34] L. Scott. Verigene® Gram-Positive Blood Culture Nucleic Acid Test , 2013, Molecular Diagnosis & Therapy.
[35] G. Plano,et al. The SycN/YscB chaperone-binding domain of YopN is required for the calcium-dependent regulation of Yop secretion by Yersinia pestis , 2013, Front. Cell. Inf. Microbio..
[36] A. Friedman,et al. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens , 2012, The Journal of investigative dermatology.
[37] Jun Wang,et al. Bacteria‐Responsive Multifunctional Nanogel for Targeted Antibiotic Delivery , 2012, Advanced materials.
[38] M. Faramarzi,et al. Biosynthesis and recovery of rod-shaped tellurium nanoparticles and their bactericidal activities , 2012 .
[39] Yu-Chie Chen,et al. Human serum albumin stabilized gold nanoclusters as selective luminescent probes for Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. , 2012, Analytical chemistry.
[40] J. Santamaría,et al. Mesoporous silica loaded with peracetic acid and silver nanoparticles as a dual-effect, highly efficient bactericidal agent , 2012 .
[41] V. Zharov,et al. In Vivo Magnetic Enrichment, Photoacoustic Diagnosis, and Photothermal Purging of Infected Blood Using Multifunctional Gold and Magnetic Nanoparticles , 2012, PloS one.
[42] Costas Kiparissides,et al. Recent advances in nanocarrier-based mucosal delivery of biomolecules. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[43] P. Tran,et al. Nanomaterial-based treatments for medical device-associated infections. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.
[44] S. Boyle,et al. Nanomedicine for intracellular therapy. , 2012, FEMS microbiology letters.
[45] Amanda C. Engler,et al. Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections , 2012 .
[46] Adam J. Friedman,et al. The potential of nitric oxide releasing therapies as antimicrobial agents , 2012, Virulence.
[47] K. Arévalo-Niño,et al. Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm , 2012, International journal of nanomedicine.
[48] Shantikumar V. Nair,et al. Flexible and microporous chitosan hydrogel/nano ZnO composite bandages for wound dressing: in vitro and in vivo evaluation. , 2012, ACS applied materials & interfaces.
[49] Robert Langer,et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.
[50] T. Lu,et al. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. , 2012, ACS nano.
[51] M. Schoenfisch,et al. Examination of bacterial resistance to exogenous nitric oxide. , 2012, Nitric oxide : biology and chemistry.
[52] Buchang Zhang,et al. Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera , 2012, Proceedings of the National Academy of Sciences.
[53] Omid C Farokhzad,et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.
[54] Nicole Rusk. Microbiology: Prokaryotic RNAi , 2012, Nature Methods.
[55] Jun Wang,et al. Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery. , 2012, Journal of the American Chemical Society.
[56] Jeffrey I. Zink,et al. Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles , 2012, Antimicrobial Agents and Chemotherapy.
[57] J. Jang,et al. Aqueous synthesis of silver nanoparticle embedded cationic polymer nanofibers and their antibacterial activity. , 2012, ACS applied materials & interfaces.
[58] Young Jik Kwon,et al. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[59] A. Mohan,et al. Antimicrobial photodynamic therapy: An overview , 2011, Journal of Indian Society of Periodontology.
[60] Wean Sin Cheow,et al. The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics , 2011 .
[61] J. Whittum-Hudson,et al. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. , 2011, Biomaterials.
[62] A. Friedman,et al. The growing role of nanotechnology in combating infectious disease , 2011, Virulence.
[63] C. J. Martel,et al. CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets , 2011, PloS one.
[64] S. Dow,et al. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. , 2011, Vaccine.
[65] Omid C Farokhzad,et al. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.
[66] Hua Ai,et al. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. , 2011, Accounts of chemical research.
[67] J. Hedrick,et al. Biodegradable nanostructures with selective lysis of microbial membranes. , 2011, Nature chemistry.
[68] M. Veerapandian,et al. Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications , 2011, Applied Microbiology and Biotechnology.
[69] Michael R Hamblin,et al. Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections , 2011, Antimicrobial Agents and Chemotherapy.
[70] M. Potara,et al. Synergistic antibacterial activity of chitosan–silver nanocomposites on Staphylococcus aureus , 2011, Nanotechnology.
[71] Kenneth Vecchio,et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. , 2011, Journal of the American Chemical Society.
[72] Jun Fang,et al. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.
[73] Morteza Mahmoudi,et al. Effect of nanoparticles on the cell life cycle. , 2011, Chemical reviews.
[74] Karine Glinel,et al. Bactericidal microparticles decorated by an antimicrobial peptide for the easy disinfection of sensitive aqueous solutions. , 2011, Biomacromolecules.
[75] Leo H. Koole,et al. New Strategies in the Development of Antimicrobial Coatings: The Example of Increasing Usage of Silver and Silver Nanoparticles , 2011 .
[76] B. Allegranzi,et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis , 2011, The Lancet.
[77] M. Giazzon,et al. Silver-polysaccharide nanocomposite antimicrobial coatings for methacrylic thermosets. , 2011, Acta biomaterialia.
[78] Chun-Ming Huang,et al. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. , 2011, Biomaterials.
[79] George A. Calin,et al. RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.
[80] A. Boccaccini,et al. Titania and titania–silver nanocomposite coatings grown by electrophoretic deposition from aqueous suspensions , 2010 .
[81] H. Carleton. Pathogenic Bacteria as Vaccine Vectors: Teaching Old Bugs New Tricks , 2010, The Yale journal of biology and medicine.
[82] Ming Kong,et al. Antimicrobial properties of chitosan and mode of action: a state of the art review. , 2010, International journal of food microbiology.
[83] W. D. de Jong,et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.
[84] Xiaohu Gao,et al. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. , 2010, Chemical Society reviews.
[85] H. Kim,et al. Structural, thermal, mechanical and bioactivity evaluation of silver-loaded bovine bone hydroxyapatite grafted poly(ε-caprolactone) nanofibers via electrospinning , 2010 .
[86] Saber M Hussain,et al. Metal-based nanoparticles and their toxicity assessment. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[87] C. Malic,et al. Use of Acticoat dressings in burns: what is the evidence? , 2010, Burns : journal of the International Society for Burn Injuries.
[88] Robert Langer,et al. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.
[89] N. Monteiro-Riviere,et al. Intrinsic biological property of colloidal fullerene nanoparticles (nC60): lack of lethality after high dose exposure to human epidermal and bacterial cells. , 2010, Toxicology letters.
[90] Xingyu Jiang,et al. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. , 2010, Journal of the American Chemical Society.
[91] K. Wong,et al. Silver nanoparticles—the real “silver bullet” in clinical medicine? , 2010 .
[92] M. Mitrić,et al. Synthesis, characterization and antimicrobial activity of copper and zinc-doped hydroxyapatite nanopowders , 2010 .
[93] M. Veerapandian,et al. Glucosamine-functionalized silver glyconanoparticles: characterization and antibacterial activity , 2010, Analytical and Bioanalytical Chemistry.
[94] R. Pignatello,et al. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. , 2010, International journal of antimicrobial agents.
[95] Kenneth Vecchio,et al. Stimuli-responsive liposome fusion mediated by gold nanoparticles. , 2010, ACS nano.
[96] Dakrong Pissuwan,et al. Functionalised gold nanoparticles for controlling pathogenic bacteria. , 2010, Trends in biotechnology.
[97] Abdelwahab Omri,et al. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. , 2010, The Journal of antimicrobial chemotherapy.
[98] Cristina Rodríguez Padilla,et al. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria , 2010 .
[99] S. Santra,et al. Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. , 2010, Advanced drug delivery reviews.
[100] G Greub,et al. Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Bacterial Strains Routinely Isolated in a Clinical Microbiology Laboratory , 2010, Journal of Clinical Microbiology.
[101] Chun-Ming Huang,et al. Development of nanoparticles for antimicrobial drug delivery. , 2010, Current medicinal chemistry.
[102] I. Chopra,et al. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections , 2010, Nature Reviews Microbiology.
[103] J. Lipuma,et al. Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine , 2010, Medical Microbiology and Immunology.
[104] J. Readman,et al. An investigation into the effects of silver nanoparticles on antibiotic resistance of naturally occurring bacteria in an estuarine sediment. , 2009, Marine environmental research.
[105] Ueli Aebi,et al. A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria1 , 2009, The Journal of Immunology.
[106] J. Friedman,et al. Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection , 2009, PloS one.
[107] Hao Li,et al. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7 , 2009, Journal of applied microbiology.
[108] Adam J Friedman,et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. , 2009, The Journal of investigative dermatology.
[109] Aharon Gedanken,et al. Antibiofilm activity of nanosized magnesium fluoride. , 2009, Biomaterials.
[110] Hongxiang Sun,et al. ISCOMs and ISCOMATRIX. , 2009, Vaccine.
[111] Weimin Fan,et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. , 2009, Nature nanotechnology.
[112] P. Andersen,et al. A Liposome-Based Mycobacterial Vaccine Induces Potent Adult and Neonatal Multifunctional T Cells through the Exquisite Targeting of Dendritic Cells , 2009, PloS one.
[113] Tao Chen,et al. Novel Anion Liposome-Encapsulated Antisense Oligonucleotide Restores Susceptibility of Methicillin-Resistant Staphylococcus aureus and Rescues Mice from Lethal Sepsis by Targeting mecA , 2009, Antimicrobial Agents and Chemotherapy.
[114] M. Schoenfisch,et al. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. , 2009, Biomaterials.
[115] P. Sansonetti,et al. Life on the inside: the intracellular lifestyle of cytosolic bacteria , 2009, Nature Reviews Microbiology.
[116] Ivan Donati,et al. Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. , 2009, Biomacromolecules.
[117] U. Aebi,et al. Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants. , 2009, Journal of molecular biology.
[118] R. Scott,et al. The Direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention , 2009 .
[119] A. Almeida,et al. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles. , 2009, Biomaterials.
[120] Robert Langer,et al. Impact of nanotechnology on drug delivery. , 2009, ACS nano.
[121] R. Jayaraman,et al. Antibiotic resistance: an overview of mechanisms and a paradigm shift , 2009 .
[122] Michael V. Liga,et al. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. , 2008, Water research.
[123] C. Kaittanis,et al. Rapid Nanoparticle-Mediated Monitoring of Bacterial Metabolic Activity and Assessment of Antimicrobial Susceptibility in Blood with Magnetic Relaxation , 2008, PloS one.
[124] Y. Shai,et al. Antimicrobial lipopolypeptides composed of palmitoyl Di- and tricationic peptides: in vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action. , 2008, Biochemistry.
[125] H. Karlsson,et al. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. , 2008, Chemical research in toxicology.
[126] J. Friedman,et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. , 2008, Nitric oxide : biology and chemistry.
[127] D. M. Eby,et al. Synthesis of bioinorganic antimicrobial peptide nanoparticles with potential therapeutic properties. , 2008, Biomacromolecules.
[128] Gary Taubes,et al. The Bacteria Fight Back , 2008, Science.
[129] R. Banerjee,et al. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.
[130] Menachem Elimelech,et al. Antibacterial effects of carbon nanotubes: size does matter! , 2008, Langmuir : the ACS journal of surfaces and colloids.
[131] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[132] T. Seki,et al. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[133] B. Gibbins,et al. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.
[134] Yunqing Kang,et al. Toxicological effect of ZnO nanoparticles based on bacteria. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[135] Robert Langer,et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.
[136] F. Martínez-Gutiérrez,et al. Characterization of silver nanoparticles synthesized on titanium dioxide fine particles , 2008, Nanotechnology.
[137] C. Russell Middaugh,et al. Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.
[138] C. Kaittanis,et al. Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility. , 2008, Analytical chemistry.
[139] M. Schoenfisch,et al. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. , 2008, ACS nano.
[140] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[141] Menachem Elimelech,et al. Single-walled carbon nanotubes exhibit strong antimicrobial activity. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[142] Michael K. Seery,et al. Silver Doped Titanium Dioxide Nanomaterials for Enhanced Visible Light Photocatalysis , 2007 .
[143] James R. Baker,et al. Mucosal Immunization with a Novel Nanoemulsion-Based Recombinant Anthrax Protective Antigen Vaccine Protects against Bacillus anthracis Spore Challenge , 2007, Infection and Immunity.
[144] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[145] Weihong Tan,et al. Fluorescent nanoparticles for multiplexed bacteria monitoring. , 2007, Bioconjugate chemistry.
[146] Dae Hong Jeong,et al. Antimicrobial effects of silver nanoparticles. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[147] J. Guggenbichler,et al. Biocompatibility testing of a new silver-impregnated catheterin vivo , 2007, Infection.
[148] E. Manias. Nanocomposites: stiffer by design. , 2007, Nature materials.
[149] Jian Ji,et al. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex. , 2006, Journal of biomedical materials research. Part A.
[150] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[151] Volker Wagner,et al. The emerging nanomedicine landscape , 2006, Nature Biotechnology.
[152] Paul Leonard,et al. The development of rapid fluorescence-based immunoassays, using quantum dot-labelled antibodies for the detection of Listeria monocytogenes cell surface proteins. , 2006, International journal of biological macromolecules.
[153] H. Sahl,et al. The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.
[154] Delina Y Lyon,et al. Antibacterial activity of fullerene water suspensions: effects of preparation method and particle size. , 2006, Environmental science & technology.
[155] Chad A Mirkin,et al. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange , 2006, Nature Protocols.
[156] R. Paranjape,et al. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. , 2005, Vaccine.
[157] M. Gleave,et al. Antisense therapy for cancer , 2005, Nature Reviews Cancer.
[158] Jan Holmgren,et al. Mucosal immunity and vaccines , 2005, Nature Medicine.
[159] S. Plotkin,et al. Vaccines: past, present and future , 2005, Nature Medicine.
[160] Yu-Chie Chen,et al. Affinity capture using vancomycin-bound magnetic nanoparticles for the MALDI-MS analysis of bacteria. , 2005, Analytical chemistry.
[161] Ben Wong,et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? , 2004, The Journal of antimicrobial chemotherapy.
[162] Zi-rong Xu,et al. Preparation and antibacterial activity of chitosan nanoparticles. , 2004, Carbohydrate research.
[163] Lisa R. Hilliard,et al. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[164] Michael Wagener,et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. , 2004, Biomaterials.
[165] N. Huang,et al. The effects of amorphous carbon films deposited on polyethylene terephthalate on bacterial adhesion. , 2004, Biomaterials.
[166] Viswanadham Garimella,et al. Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes , 2004, Nature Biotechnology.
[167] R. Darouiche,et al. Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.
[168] Walter Steurbaut,et al. Chitosan as antimicrobial agent: applications and mode of action. , 2003, Biomacromolecules.
[169] Bing Xu,et al. Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities , 2003 .
[170] R. Curtiss. Bacterial infectious disease control by vaccine development. , 2002, The Journal of clinical investigation.
[171] C. Mirkin,et al. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. , 2002, Science.
[172] K. Poole. Mechanisms of bacterial biocide and antibiotic resistance , 2002, Journal of applied microbiology.
[173] M. Taylor,et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. , 2002, Kidney international.
[174] B. Morein,et al. Immunostimulating complexes (ISCOMs) for nasal vaccination. , 2001, Advanced drug delivery reviews.
[175] S. Kwak,et al. Hybrid organic/inorganic reverse osmosis (RO) membrane for bactericidal anti-fouling. 1. Preparation and characterization of TiO2 nanoparticle self-assembled aromatic polyamide thin-film-composite (TFC) membrane. , 2001, Environmental science & technology.
[176] Peter E. Nielsen,et al. Bactericidal antisense effects of peptide–PNA conjugates , 2001, Nature Biotechnology.
[177] J. Baker,et al. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. , 2001, Microbiological research.
[178] G. O’Toole,et al. Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.
[179] Mitchell L. Cohen. Changing patterns of infectious disease , 2000, Nature.
[180] S. Trerotola. Hemodialysis catheter placement and management. , 2000, Radiology.
[181] R. Pinner,et al. Trends in infectious disease mortality in the United States during the 20th century. , 1999, JAMA.
[182] V. Yu,et al. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. , 1999, International journal of antimicrobial agents.
[183] J. Storhoff,et al. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. , 1997, Science.
[184] M. N. Jones,et al. The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature. , 1996, Biochimica et biophysica acta.
[185] J. Kraehenbuhl,et al. Antigen sampling across epithelial barriers and induction of mucosal immune responses. , 1996, Annual review of immunology.
[186] J. Creeth,et al. The targeting of phospholipid liposomes to bacteria. , 1994, Biochimica et biophysica acta.
[187] A. Salyers,et al. Bacterial Pathogenesis: A Molecular Approach , 1994 .
[188] A. J. Clifford,et al. BIOCHIMICA ET BIOPHYSICA ACTA , 2022 .